Skip to content

The effect of Reac treatment compared to sham on the balance of individuals affected by stroke

Efficacy of Radio Electric Asymmetric Conveyer (REAC) neuromodulation treatment compared to placebo in the balance of post-Stroke individuals: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-33sd66h
Enrollment
50
Registered
2024-01-11
Start date
2023-11-16
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paresis Stroke

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 25 individuals with stroke will receive intervention with Radio Electric Asymmetric Conveyer (REAC). Control
IN, 2019). The corresponding group will be placed inside the envelope, which will later be sealed and delivered to the participant immediately after the initial assessment and then sent to carry out t

Sponsors

Pontifícia Universidade Católica do Paraná
Lead Sponsor
Asmed Latino America Comércio e Importação de Produtos Médicos Ltda
Collaborator
Hospital de Clínicas da Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male or female; aged 18 and over; diagnosis of right or left hemispheric stroke of ischemic or hemorrhagic origin; physiotherapeutic diagnosis of right or left hemiparesis due to stroke; chronic cerebrovascular injury (injury time greater than 6 months); absence of obvious orthopedic or neurological disorders not resulting from the stroke that could interfere with balance; absence of rheumatic disorders with joint involvement of the lower limbs; have not participated in other clinical trials related to the use of transcranial stimulation within one month; use of medications that may interfere with the assessment of study efficacy, such as opioids, barbiturates, benzodiazepines and antipsychotics; ability to understand and execute simple verbal commands; ability to remain upright for at least 60 seconds without the need for human support or an assistive device; ability to walk without human assistance, being allowed to use an auxiliary device

Exclusion criteria

Exclusion criteria: Failing to complete assessments of outcome measures before and after Radio Electric Asymmetric Conveyer (REAC) treatment with NPO (neurpostural optimization) protocol. Instability of vital signs at the time of study procedures. Report of dizziness at the time of the data collection procedure

Design outcomes

Primary

MeasureTime frame
An increase of approximately 6 points on the Berg Balance Scale is expected immediately after treatment with Radio Electric Asymmetric Conveyer (REAC)

Secondary

MeasureTime frame
A 10% reduction in the time required for the Time Up and Go Test is expected immediately after treatment with Radio Electric Asymmetric Conveyer (REAC);It is expected that the functional dysmetria determined by the Functional Dysmetria Test will disappear after treatment with the Radioelectric Asymmetric Transporter (REAC);A reduction in the asymmetry of the center of pressure area under each foot, as determined by posturography, is expected after application of the Radio Electric Asymmetric Conveyer (REAC) treatment.;A reduction in weight-bearing asymmetry between the feet, as determined by posturography, is expected after treatment with Radio Electric Asymmetric Conveyer (REAC).;Improved synchronization of the center of pressure, as determined by posturography, is expected after treatment with Radio Electric Asymmetric Conveyer (REAC)

Countries

BR

Contacts

Public ContactVinícius Machado

Pontifícia Universidade Católica do Paraná

gomes.machado@pucpr.edu.br+55 (41) 3271-2103

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Jun 11, 2026